Links between impulsive-compulsive behaviors (ICBs) in treated Parkinson's disease (PD), behavioral addictions, and substance abuse have been postulated, but no direct comparisons have been carried out so far. We directly compared patients with PD with and without ICBs with illicit drug abusers, pathological gamblers, and age-matched healthy controls using the beads task, a test of reflection impulsivity, and a working memory task. We found that all patients with PD made more impulsive and irrational choices than the control group. PD patients who had an ICB showed similar behavior to illicit substance abusers, whereas patients without ICBs more closely resembled pathological gamblers. In contrast, we found no difference in working memory performance within the PD groups. However, PD patients without ICBs remembered distractors significantly less than all other patients during working memory tests. We were able to correctly classify 96% of the PD patients with respect to whether or not they had an ICB by analyzing three trials of the 80/20 loss condition of the beads task with a negative prediction value of 92.3%, and we propose that this task may prove to be a powerful screening tool to detect an ICB in PD. Our results also suggest that intact cortical processing and less distractibility in PD patients without ICBs may protect them from developing behavioral addictions. V C 2012 Movement Disorder Society
Although not necessarily maladaptive, impulsive decision making is often linked with addiction and has been reported in patients with substance abuse and pathological gambling. 1, 2 It is also observed in a subgroup of patients with Parkinson's disease (PD) who develop impulsive-compulsive behaviors (ICBs) on dopaminergic medication. 3 Approximately 14% of PD patients treated with dopamine receptor agonists (DAAs) alone develop ICBs, such as pathological gambling, compulsive sexual behavior, binge eating, excessive shopping, and punding. history of substance abuse. 5 ICBs have also been associated with ''behavioral addictions,'' 6 sharing clinical withdrawal symptoms of dysphoria, depression, and anxiety 7, 8 with substance abuse. Functional imaging studies have demonstrated aberrant striatal dopaminergic ''reward pathways'' and altered function in frontal cortical regions in PD patients with ICBs (PDþICB) and non-PD patients with addictive behaviors. 7, 9, 10 We have used the ''beads task'' 11 to compare decision making in PD patients with and without ICBs, pathological gamblers, and substance abusers. In addition to the Mini-Mental State Examination (MMSE), 12 we also included a working memory (WM) task to assess whether impairments in decision making reflected a more generalized cognitive deficit. The beads task assesses how much information participants gather before making a decision that has been referred to as ''reflection impulsivity.'' 13, 14 This differs from ''motor'' impulsivity, the inability to stop an ongoing process, and from ''waiting'' impulsivity, the inability to delay an action. 15 Early decision on the beads task or ''jumping to conclusions'' has been also observed in patients with schizophrenia. [16] [17] [18] In a modified version of this task, a positive association between impulsivity and problem gambling has been reported. 19 Reflection impulsivity has been also described in opioid abusers previously 14 and has been shown not to correlate with scores on Barratt's impulsiveness scale. 20 We predicted that all impulsive patients would jump to conclusions and speculated that PDþICB patients would show behavior similar to substance abusers and pathological gamblers and make choices that were more impulsive than PD patients without ICBs (PD-ICB). We also speculated that both PD groups would perform worse than matched controls, given recent studies showing that even PD-ICB patients show increased risk taking and temporal discounting. 21, 22 Negative effects of task-irrelevant stimuli (¼distractors) on WM performance have been reported on. 23 Given our previous results on WM performance, 21 we hypothesized that PDþICB patients would perform significantly worse than controls and PD-ICB patients on the WM task and might have a performance similar to that observed in pathological gamblers and substance abusers. We also speculated that all patients with addictions would remember distractors significantly better than controls and PD-ICB patients.
Patients and Methods
All participants provided written informed consent according to the Declaration of Helsinki and the study was approved by the UCLH Trust and the University of Lviv Ethics Committee.
PD and Elderly Control Groups
Twenty-seven PD-ICB and 26 PDþICB patients were recruited from the National Hospital for Neurology and Neurosurgery (London, UK). All patients fulfilled the Queen Square Brain Bank criteria for the diagnosis of PD 24 and were taking levodopa. Twentyone of twenty-seven PD-ICB patients were taking a DAA, whereas only 13 of 26 PDþICB patients were still on a DAA. Eighteen healthy matched elderly volunteers were recruited. Patients who scored under 26 of 30 points on the MMSE were excluded. All participants were screened for subclasses of ICBs in a semistructured interview, using accepted diagnostic criteria for pathological gambling, 25 compulsive shopping, 26 compulsive sexual behavior, 27 and punding. 28 We also used a self-rated validated questionnaire for impulsive compulsive disorders in PD (QUIP). 29 Patients were tested only ''on'' medication with the beads test to minimize ''off'' dysphoria and anxiety, 30 which was, however, not specifically measured.
For the WM task, patients were tested both off and on medication, in a counterbalanced order. Patients who were tested ''off medication'' did not take their anti-PD medication for at least 12 hours and performed the task between 8.00 a.m. and 9.00 a.m. They were then retested ''on medication'' the following day. Those patients who were tested on medication first performed this task usually in midmorning when their motor symptoms were well controlled. They were revisited on the following day before their medication for the second test. Controls were tested in the same way, but did not take any anti-PD medication. All PD patients had an excellent L-dopa response assessed by UPDRS part III scores during the off and on state. L-dopa equivalent units (LEUs; Table 1) were calculated as described previously 28 (see Supporting Materials).
Pathological Gamblers, Substance Abusers, and Matched Controls
These participants were tested once, usually midmorning. Twenty-three patients with pathological gambling, according to Diagnostic and Statistical Manual of Mental Disorder, Fourth Edition (DSM-IV), criteria 25 were recruited from the National Problem Gambling Clinic (London, UK). Most gamblers only stopped gambling after recent financial ruin. All were help-seeking and awaiting treatment. None had a current history of substance abuse. Thirteen patients with a recent history of illicit substance abuse, meeting DSM-IV criteria for substance dependence, 25 were also tested. Patients were recruited from the Replacement Therapy Unit of Lviv (Lviv, Ukraine) and were receiving buprenorphine. None fulfilled DSM-IV criteria for dementia. Twelve of thirteen patients had a long-standing history of intravenous (IV) opioid abuse (see Table 1 ).
All pathological gamblers and 12 of 13 of the substance abusers were males. Results were compared with 18 age-matched male controls.
Beads Task
The beads task 11 was performed on a laptop computer, usually in the participant's home or in a quiet room to minimize distractions. Participants were required to guess from which of two cups colored beads were being drawn. The cups differed in the proportion of blue and green beads they contained. For example, one of the cups may have contained 80% blue beads and 20% green beads, whereas the other cup may have contained 80% green beads and 20% blue beads. Participants were first shown a bead draw, which was either blue or green. They could then draw another bead or guess that the bead was being drawn from the predominantly green or blue cup. This was repeated until they chose to guess one of the cups. We were interested in the number of beads drawn before the participant guessed a cup and whether the urn choice represented a rational (e.g., if more blue beads were drawn the participant guessed blue) or irrational (i.e., the cup color guessed was not most probably correct, given the beads drawn) choice. This is referred to as opposite color choice. All values are mean 6 standard deviation. Controls (CO-O, elderly controls; CO-Y, young controls), PD patients with (PDþICB) and without (PD-ICB) ICBs, addicts (¼illicit substance abusers), and pathological gamblers. *Significant differences.
Participants completed four blocks of three trials each. Two blocks contained an 80/20 ratio of beads, and two blocks a 60/40 ratio of beads in each cup (see Supporting Materials).
WM Task
PD patients were tested before and after their usual anti-PD medication in a counterbalanced sequence to account for order effects. Twenty-four trials of a WM task were completed on a laptop computer (Supporting Fig. 1 ). Participants were asked to memorize either two or three geometric figures, which were shown for 3 seconds, followed by a delay of 2 seconds. During the delay, distractor images were shown. Then, another geometric figure was presented and participants were asked whether this figure was within the set that they had to remember before. In half of the trials, two geometric figures, and in the other half three, had to be remembered. Distractors could be positive, neutral, or negative images taken from the validated International Affective Picture System. 31 At the end, participants were shown 24 distractor images and were asked whether they thought they had seen the images before. Half of the distractors were shown during the WM task (see Supporting Materials).
Results

Demographic and Clinical Features
Demographic variables (Table 1) were analyzed using analysis of variance, t test, or chi-square, tests, where appropriate. There were no differences between the control groups and the matched patient groups on any demographic variables. Significantly more PD-ICB (21 of 27) than PDþICB (13 of 26) patients were taking a DAA (P ¼ 0.024), which is in line with accepted clinical guidelines of managing an ICB in PD. Consistent with the literature, 4 PDþICB patients showed a trend to be younger than PD-ICB patients and had a significantly younger disease onset, relative to PD-ICB patients (t 52 ¼ 3.28; p ¼ 0.002) (see Supporting Material).
Beads Task
We examined the number of draws each participant made in the different conditions (Fig. 1A) (for total numbers draws per group, see Table 1 ). We found significant effects of group (Wald's v 2 ¼ 191.0; P < 0.001), beads ratio (Wald's v 2 ¼ 167.9; P < 0.001) and a significant beads ratio by loss condition interaction (Wald's v 2 ¼ 9.4; P ¼ 0.002). There was no difference between the two control groups on number of draws (Wald's v 2 ¼ 1.0; P > 0.3). There was also no correlation between age and number of draws in the control groups (r ¼ À0.15; P > 0.37). We therefore combined the two control groups and performed pairwise comparisons between the PDþICB group and the other groups to examine whether or not the PDþICB group would perform similarly to the other groups ( Table 2) .
We found that PDþICBs were drawing significantly fewer beads than PD-ICBs (Wald's v 2 ¼ 27.1; P < 0.001), pathological gamblers (Wald's v 2 ¼ 13.9; P < 0.001), and controls (Wald's v 2 ¼ 75.1; P < 0.001). For completeness, we also report comparisons between the other groups ( Table 2 ). All pairwise comparisons showed main effects of beads ratio. Only the PD-ICB versus control pairwise comparison additionally showed an interaction between group and beads ratio (Wald's v 2 ¼ 8.0; P ¼ 0.005).
Opposite Color Choice
Next, we examined the number of times participants made an irrational choice, summed across all conditions (Fig. 1B) . We found a main effect of group (Wald's v 2 ¼ 72.1; P < 0.001) and examined effects pairwise between groups. Again, there was no difference between the two control groups (Wald's v 2 ¼ 0.07; P ¼ 0.8), so they were combined (Table 2 ). Pairwise comparisons showed that substance abusers chose the opposite color significantly more often than all other groups (all P values <0.001). Furthermore, all patients chose the opposite color significantly more often than controls (P < 0.001). There was no difference between PDþICB and PD-ICB patients or pathological gamblers.
Classification of PD1ICBs on the Basis of Drawing Behavior
We used the drawing behavior of individual participants in the 80/20 loss condition to try to predict group membership between the PDþICB and PD-ICB groups. We used an unblended, supervised classification technique, which required labeled data and found that we correctly classified 25 of 26 (>96%) PDþICB patients. We also correctly classified 44% of PD-ICB patients as not having an ICB, giving a positive predictive value of 62.5% and a negative predictive value of 92.3%.
WM Task
Detailed results are reported in the Supporting Materials. For the WM performance, pairwise comparison showed that all groups performed better than substance abusers (Table 3) , but there were no differences between all the other groups ( Fig. 2A) . For remembering distractors in the WM task, we found All P values shown are uncorrected. Values less than 0.0125 are significant.
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that a main effect of group (Wald's v 2 ¼ 59.7; P < 0.001) and pairwise comparisons showed that PDþICB patients (Wald's v 2 ¼ 7.2; P ¼ 0.007) and pathological gamblers (Wald's v 2 ¼ 15.4; P < 0.001) remembered distractors significantly better than PD-ICB patients (Table 3 ; Fig. 2B ).
QUIP Questionnaires
Consistent with previous studies, 29, 32 we found a high sensitivity to detect an ICB (96.1%) for both the patient-and caregiver-rated QUIP. A total of 40.7% of PD-ICB patients, who did not meet the diagnostic criteria for having an ICB, had at least one ICB symptom either self-rated or by their caregiver, consistent with a previous study. 32 There was no correlation of the QUIP and drawing behavior (see Supporting Materials).
Discussion and Conclusion
We have examined ''reflection impulsivity'' using the beads task, an information-gathering paradigm in which participants controlled the amount of information they gathered before making a decision. 11 We compared PD patients with and without ICBs, pathological gamblers, and substance abusers and found evidence for impairment, even in treated PD patients without clinically apparent ICBs. Across groups, we found an effect of the beads ratios, such that participants drew more when the beads ratios were closer to chance (60/40) than when the ratio was greater between the cups (80/20). Further, the loss condition interacted with the beads ratio condition, such that subjects drew relatively more in the higher loss conditions. Despite all groups showing behavior adaptive to the specific condition, the PDþICB group drew significantly fewer beads than controls, PD-ICBs, and pathological gamblers before making a decision. Significantly less PDþICB than PD-ICB patients were taking a DAA and yet they still gathered less information. The fact that the PDþICB group drew fewer beads than pathological gamblers is intriguing, given that half of the PDþICB patients had clinically defined pathological gambling. Slot machines, scratch cards, and bingo were the most commonly played gambles in PD; pathological gamblers preferred skilled games, such as spread betting and electronic casino games (see Table 1) , [33] [34] [35] which may be of relevance in the interpretation of the results.
Direct comparison between groups on the beads task suggests greater similarities between PDþICB patients and substance abusers, compared to the pathological gamblers or PD-ICB patients. PET studies have shown sensitization of the ventral striatum in PDþICB patients 36, 37 and also in patients with substance abuse. 10, 38 . Furthermore, reflection impulsivity does not recover, even after prolonged abstinence in substance abusers.
14 This is consistent with the fact that DAAs have often been withdrawn for a long period in the PDþICB group, leading to alleviation of impulsive symptoms, and yet they still make impulsive choices in the beads task. PDþICB patients also become irritable when their addictive behavior is restricted, 28 ,39 reminiscent of withdrawal symptoms in drug abusers.
Analysis of the QUIP revealed that 41% of PD-ICB patients had at least one symptom of an ICB, either self-rated or rated by their caregiver consistent with previous studies. 32 Using the beads tasks, we classified 56% of PD-ICB patients as having tendencies toward impulsivity, suggesting that this task may be a more sensitive screening tool to detect hidden impulsive traits. Consistent with this, there was no difference in the behavioral pattern between PD-ICB patients and pathological gamblers. This is particularly interesting, because none of the gamblers had received any treatment for their impulsivity and none of the PD-ICB patients had clinically defined ICBs. We also found that PD-ICB patients drew significantly less than matched controls. Several studies have demonstrated increased impulsivity and changes on behavioral tasks in PD-ICB patients after starting dopaminergic medication, [40] [41] [42] in contrast to treatment-naïve PD patients who perform similarly to controls. 43 Whether impulsivity arises as a result of increased impulsive drive, decreased inhibitory control, or a combination of both is still unclear. However, the results in the PD-ICB group could reflect an underlying increased impulsivity driven by excessive dopamine levels in the ventral striatum. In PD, there is much less dopamine loss in the ventral than the dorsal striatum. 44 Therefore, treatment with dopaminergic medication to increase dopamine levels in the dorsal striatum may lead to excessive levels in the ventral striatum. This may result in a tendency, in all treated patients, to increased impulsivity, which, however, does not manifest as clinically significant impulsiveness because of intact inhibitory corticostriatal pathways. Hypoactivation of the orbitofrontal cortex is observed in pathological gamblers, illicit substance abusers, 45, 46 and in treated PDþICB patients, but not in PD-ICB patients. 8 The ventromedial plus the orbitofrontal part of the prefrontal cortex is important for impulse control 8, 47, 48 and is associated with jumping to conclusions on the beads task. 49 Thus, intact inhibitory control driven by these cortical areas might prevent PD-ICB patients from clinical impulsivity. 8 Jumping to conclusions can also occur in psychosis. 18 Consistent with this, previous work has shown that PDþICB participants score highly on measures of schizotypy, a personality trait related to psychosis. 50 Delusional thinking, defined as a belief based on incorrect inference, 25 has been reported in PDþICB patients 35, 51 and has been positively correlated with fewer draws on the beads task in delusional patients with and without schizophrenia. 17 Both PD groups also guessed the opposite color more often than controls, and, anecdotally, some stated that they ''anticipated'' that the opposite color was more likely and therefore chose the less likely cup. In fact, there was no group difference between PD patients and pathological gamblers. However, substance abusers chose the opposite color significantly more often than the other groups.
There are important differences between risk-taking behavior, temporal discounting, and the beads task. Previous studies have found no 21 or restricted 52 group differences in risk taking between PDþICB and PD-ICB patients. In contrast, results on the beads task in the two PD groups were highly significant. The standard temporal discounting task 3 is more closely related to self-report questionnaires than metric tasks and measures sensitivity to rewards delayed by weeks or months. In contrast, drawing more beads only delayed possible rewards by seconds. Not drawing often leads to not winning, or losing in the loss blocks, which contrasts with waiting for a larger reward, as occurs with temporal discounting.
Because memory plays an important role in reward learning, 53 we examined whether the results on the beads task could have been confounded by poor WM. In this WM task, we examined the role of distractibility during the delay interval. There was no correlation between the beads task and WM capacity, which suggests that early decisions relating to the beads were not driven by poor cognitive capacity. We also found that substance abusers had a significantly worse WM capacity than the other groups. This is consistent with previous studies demonstrating poorer attention in substance abusers when required to ignore salient stimuli during WM tasks. 54 However, this finding has to be interpreted with caution, because the substance abusers were taking opioid replacement therapy, which is known to interfere with WM function. 55 Many patients with ICBs conceal their behavior because of shame or denial. 56 By analyzing data from the 80/20 loss condition, we were able to correctly identify ICB patients with a sensitivity of 96%. The beads task might therefore provide a simple screening tool to detect patients at greater risk of ICBs or confirm a clinically suspected, but concealed, ICB. These results also suggest that a significant proportion of PD-ICB patients is at risk of developing impulsive behavior and thus, over time, may develop ICBs. 57 Poor performance on this task suggests that these patients should be monitored frequently by their treating physician and the results taken into consideration when deciding on the use of dopamine agonist treatment. This study is free from the limitations of an indirect study design 58 and contains a large number of different groups. Furthermore, our results also might have clinical implications, because they imply that PDþICB patients should be treated like substance abusers, rather than patients with behavioral addictions. Additional studies comparing PD-ICB patients on and off DAAs will be necessary to explore the role of dopaminergic medication in cognitive impulsivity.
